Results 151 to 160 of about 59,724 (178)
Some of the next articles are maybe not open access.

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Proceedings of the National Academy of Sciences of the United States of America, 2020
Jacqueline Cronin   +2 more
exaly  

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses

Frontiers in Immunology, 2020
Mengyuan Li   +2 more
exaly  

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge

Measurement: Journal of the International Measurement Confederation, 2021
Noel Nesakumar, Indhu Suresh
exaly  

MERS-COV VACCINE

2021
KANG CHIL-YONG   +3 more
openaire   +2 more sources

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions

Biomedical Journal, 2021
Husam Qanash   +2 more
exaly  

MERS-COV INHIBITOR PEPTIDES

2021
ELSAYED MAHMOUD KANDEEL   +3 more
openaire   +3 more sources

[MERS-CoV: A current review].

Zentralblatt fur Arbeitsmedizin, Arbeitsschutz und Ergonomie
The following article gives a current overview of the newly emerging Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Since first time in summer 2012 in some countries in the Arabian Peninsula there were a number of severe infections of the respiratory tract caused by the new coronavirus.
Matthias, Bundschuh   +1 more
openaire   +1 more source

[Current overview on MERS-CoV].

Zentralblatt fur Arbeitsmedizin, Arbeitsschutz und Ergonomie
The Middle East respiratory syndrome coronavirus (MERS-CoV) was discovered for the first time in Saudi Arabia in 2012. On a global scale 1200 infections have been registered with approximately 50 % resulting in a fatal outcome. It is currently not fully clear how MERS-CoV is transmitted and insufficient research has so far been carried out.
K, Schwarz, D A, Groneberg
openaire   +1 more source

Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea

Clinical Infectious Diseases, 2016
Young-Jae Si   +2 more
exaly  

Home - About - Disclaimer - Privacy